• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Clearside Biomedi (NQ: CLSD )

    1.150 -0.050 (-4.17%)
    Streaming Delayed Price Updated: 1:06 PM EDT, Sep 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 196,791
    Open 1.200
    Bid (Size) 1.140 (15)
    Ask (Size) 1.160 (5)
    Prev. Close 1.200
    Today's Range 1.150 - 1.202
    52wk Range 0.6501 - 2.120
    Shares Outstanding 61,666,130
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CLSD Stock Earnings: Clearside Biomedical Beats EPS, Misses Revenue for Q2 2024
    CLSD stock results show that Clearside Biomedical beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Why Is Clearside Biomedical Stock Gaining Today?
    Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS... 
    Via Benzinga

    Performance

    YTD
    -10.85%
    -10.85%
    1 Month
    +13.86%
    +13.86%
    3 Month
    +6.48%
    +6.48%
    6 Month
    -33.53%
    -33.53%
    1 Year
    +35.29%
    +35.29%

    More News

    Read More
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
    Via Benzinga
    CLSD Stock Earnings: Clearside Biomedical Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Clearside Biomedical: Q4 Earnings Insights
    Via Benzinga
    Preview: Clearside Biomedical's Earnings
    Via Benzinga
    Clearside Biomedical: Q3 Earnings Insights
    Via Benzinga
    Clearside Biomedical's Earnings: A Preview
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    3 Penny Stocks That Insiders Are Buying
    Via MarketBeat
    Expensify And 2 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    7 Top Stocks Under $7
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Earnings Scheduled For March 12, 2024
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Top 5 Health Care Stocks That May Crash This Month
    Via Benzinga
    Ocular Gene Therapy: Regenxbio Data Shows Consistent Preservation Of Visual Acuity, Retinal Thickness
    Via Benzinga
    Earnings Scheduled For November 13, 2023
    Via Benzinga
    Over $2M Bet On Community Health Systems? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    3 Cheap Stocks to Buy Under $1 in October 2023
    Via InvestorPlace
    Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio
    Via Talk Markets
    Topics Initial Public Offering
    Exposures Securities Market
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.